LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

LcProt: Proteomics Longitudinal Cohort Study on Lung Cancer — Stella

View on ClinicalTrials.gov

Recruiting

Back to Lung trials

Trial locations(1 site)

China

the First Affiliated of Guangzhou Medical University, Guangzhou, Guangdong

Key details

Sponsor

The First Affiliated Hospital of Guangzhou Medical University

Enrollment target

~2,500 participants

Started

June 2019

Primary completion

December 2026

Age range

18 Years – 75 Years

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.